Clinical Trials Browser

Phase 3 × Lymphoma, Extranodal NK-T-Cell × 1 year × Clear all

NCT05700448 2026-02-05

Study of Sugemalimab (or Placebo) Plus PGemOx Regimen in Participants With Extranodal NK/T-Cell Lymphoma

Phase 3 Not yet recruiting

Lymphoma, Extranodal NK-T-Cell

NCT06953739 2025-05-01

A Study Comparing of P-GEMD Regimen Versus P-Gemox Regimen With Untreated Early-Stage NUAT or Advanced-Stage ENKTL.

Phase 3 Not yet recruiting

Lymphoma, Extranodal NK-T-Cell